Proprietary AI analyst is now available

Proteak Valuation Multiples

Discover revenue and EBITDA valuation multiples for Proteak and similar public comparables like Koszalinskie Przedsiebiorstwo Przemyslu Drzewnego, Klon, EO2, Interwood-Xylemporia and more.

Proteak Overview

About Proteak

Proteak Uno SAPI B de CV is engaged in sustainable plantation teak and manufacturing of teak wood products. The company offers a line of teak wood products such as cutting boards, butcher block carts, counter tops, teak lumber, flooring among others.


Founded

2000

HQ

Mexico

Employees

755

Financials (FY)

Revenue: $41M
EBITDA: $10M

EV

$147M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Proteak Financials

Proteak reported last fiscal year revenue of $41M and EBITDA of $10M.

In the same fiscal year, Proteak generated ($8M) in gross profit, $10M in EBITDA, and had net loss of ($26M).

Revenue (LTM)


Proteak P&L

In the most recent fiscal year, Proteak reported revenue of $41M and EBITDA of $10M.

Proteak is unprofitable as of last fiscal year, with gross margin of (20%), EBITDA margin of 24%, and net margin of (63%).

See analyst estimates for Proteak
Last FY202320242025202620272028
Revenue$41M$81M$67M$41M
Gross Profit($8M)($73K)$4M($8M)
Gross Margin(20%)(0%)6%(20%)
EBITDA$10M$7M($19M)$10M
EBITDA Margin24%9%(28%)24%
EBIT Margin(40%)(20%)(16%)(40%)
Net Profit($26M)($16M)($36M)($26M)
Net Margin(63%)(20%)(54%)(63%)
Net Debt$132M---

Financial data powered by Morningstar, Inc.

Proteak Stock Performance

Proteak has current market cap of $10M, and enterprise value of $147M.

Market Cap Evolution


Proteak's stock price is $0.01.

Proteak share price decreased by 15.1% in the last 30 days, and by 61.2% in the last year.

Proteak has an EPS (earnings per share) of $-0.02.

See more trading valuation data for Proteak
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$147M$10M6.9%-15.1%-18.1%-61.2%$-0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Proteak Valuation Multiples

Proteak trades at 3.6x EV/Revenue multiple, and 14.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Proteak

EV / Revenue (LTM)


Proteak Financial Valuation Multiples

As of June 14, 2026, Proteak has market cap of $10M and EV of $147M.

Proteak has a P/E ratio of (0.4x).

Last FY202320242025202620272028
EV/Revenue3.6x1.8x2.2x3.6x
EV/EBITDA14.5x20.3x(7.9x)14.5x
EV/EBIT(8.8x)(9.1x)(14.1x)(8.8x)
EV/Gross Profit(17.6x)n/m34.8x(17.6x)
P/E(0.4x)(0.6x)(0.3x)(0.4x)
EV/FCF106.3x34.7x35.6x106.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Proteak Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Proteak Margins & Growth Rates

In the most recent fiscal year, Proteak reported gross margin of (20%), EBITDA margin of 24%, and net margin of (63%).

See estimated margins and future growth rates for Proteak

Proteak Margins

Last FY20242025202720282029
Gross Margin(20%)6%(20%)
EBITDA Margin24%(28%)24%
EBIT Margin(40%)(16%)(40%)
Net Margin(63%)(54%)(63%)
FCF Margin3%6%3%

Proteak Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(17%)(38%)
Gross Profit Growth(5852%)(298%)
EBITDA Growth(357%)(154%)
EBIT Growth(35%)60%
Net Profit Growth124%(29%)
FCF Growth(2%)(67%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Proteak Operational KPIs

Proteak's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Proteak
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$0.0M---
S&M Expenses to Revenue5%9%9%5%
G&A Expenses to Revenue5%5%5%5%
Opex to Revenue20%20%22%20%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Proteak Competitors

Proteak competitors include Koszalinskie Przedsiebiorstwo Przemyslu Drzewnego, Klon, EO2, Interwood-Xylemporia, Rougier, Standrew, Embpar Participacoes, Werth-Holz, Med Paper and KHD Humboldt Wedag.

Most Proteak public comparables operate across Paper & Forest Products.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Koszalinskie Przedsiebiorstwo Przemyslu Drzewnego0.1x-19.5x-
Klon1.8x-(16.6x)-
EO20.5x-4.0x-
Interwood-Xylemporia----
Rougier0.3x-(6.2x)-
Standrew2.1x-17.9x-
Embpar Participacoes8.9x-(14.0x)-
Werth-Holz0.9x-(61.3x)-

This data is available for Pro users. Sign up to see all Proteak competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Proteak

When was Proteak founded?Proteak was founded in 2000.
Where is Proteak headquartered?Proteak is headquartered in Mexico.
How many employees does Proteak have?As of today, Proteak has over 755 employees.
Is Proteak publicly listed?Yes, Proteak is a public company listed on Bolsa Mexicana de Valores.
What is the stock symbol of Proteak?Proteak trades under TEAKCPO ticker.
When did Proteak go public?Proteak went public in 2010.
Who are competitors of Proteak?Proteak main competitors include Koszalinskie Przedsiebiorstwo Przemyslu Drzewnego, Klon, EO2, Interwood-Xylemporia, Rougier, Standrew, Embpar Participacoes, Werth-Holz, Med Paper, KHD Humboldt Wedag.
What is the current market cap of Proteak?Proteak's current market cap is $10M.
What is the current revenue of Proteak?Proteak's last fiscal year revenue is $41M.
What is the current EV/Revenue multiple of Proteak?Current revenue multiple of Proteak is 3.6x.
Is Proteak profitable?No, Proteak is not profitable.
How many companies Proteak has acquired to date?Proteak hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Proteak has invested to date?Proteak hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Proteak

Lists including Proteak

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial